Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Stockholders' Deficiency (Parenthetical)

v3.5.0.2
Consolidated Statement of Changes in Stockholders' Deficiency (Parenthetical)
12 Months Ended
Dec. 31, 2015
USD ($)
Derivative liabilities $ 168,316
Series C Convertible Preferred Stock [Member]  
Gross proceeds 1,930,000
Issuance costs $ 264,720